Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to $158.3 million.

  • Medifast's Retained Earnings fell 1047.22% to $158.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $158.3 million, marking a year-over-year decrease of 1047.22%. This contributed to the annual value of $158.3 million for FY2025, which is 1047.22% down from last year.
  • Per Medifast's latest filing, its Retained Earnings stood at $158.3 million for Q4 2025, which was down 1047.22% from $176.2 million recorded in Q3 2025.
  • In the past 5 years, Medifast's Retained Earnings registered a high of $203.1 million during Q1 2022, and its lowest value of $129.2 million during Q2 2022.
  • Moreover, its 5-year median value for Retained Earnings was $176.0 million (2024), whereas its average is $170.0 million.
  • As far as peak fluctuations go, Medifast's Retained Earnings skyrocketed by 6207.42% in 2021, and later tumbled by 3029.3% in 2022.
  • Quarter analysis of 5 years shows Medifast's Retained Earnings stood at $190.3 million in 2021, then dropped by 26.52% to $139.9 million in 2022, then rose by 24.88% to $174.6 million in 2023, then grew by 1.22% to $176.8 million in 2024, then decreased by 10.47% to $158.3 million in 2025.
  • Its Retained Earnings stands at $158.3 million for Q4 2025, versus $176.2 million for Q3 2025 and $178.5 million for Q2 2025.